DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Pollack Jr. CV, Reilly PA, Eikelboom J. et al.
Idarucizumab for dabigatran reversal.
N Engl J Med 2015;
373: 511-520
We do not assume any responsibility for the contents of the web pages of other providers.